Important notification
06.03.2019 To the attention of Marketing Authorisation Holders (MAHs) concerned The National Agency for Medicines and Medical Devices (NAMMD) hereby […]
Press release
03.02.2019 To the attention of interested persons EMA press release on the request addressed to pharmaceutical companies that manufacture medicinal […]
Important notification
22.10.2018 To MAH attention Given the need to reduce Brexit impact on medicine availability, please submit an updated status of […]
Important notification
19.07.2018 To the attention of interested persons The NAMMD would like to inform you about the 5th Romanian Pharmacovigilance Workshop […]
Press release
10.07.2018 To the attention of interested persons The National Agency for Medicines and Medical Devices has requested precautionary recall from […]
Important notification
10.07.2018 To the attention of interested persons The National Agency for Medicines and Medical Devices has requested precautionary recall from […]
Important notification
23.04.2018 To the attention of interested persons European Immunization Week Vaccination is a right and responsibility for all Vaccines protect […]
Press release
13.03.2018 To the attention of interested persons EMA press release: Prostate cancer medicine Xofigo must not be used with Zytiga […]
Press release
09.03.2018 To the attention of interested persons Press release: EMA recommends immediate suspension and recall of multiple sclerosis medicine Zinbryta. […]
Press release
07.03.2018 To the attention of interested persons Given the current immunoglobulin crisis on the Romanian market and publication in the […]